Bulletin of Stomatology and Maxillofacial Surgery
ISSN 1829-006X
2025; 555–563
Shared with The Gufo

COMPLICATED KLEBSIELLA PNEUMONIA INFECTION CAUSING LUNG ABSCESS: CASE REPORT

Faculty of Medicine, Universitas Airlangga, Indonesia

Received: 2026-04-08 · Published: 2025-11-28

Shared article.
Original title
COMPLICATED KLEBSIELLA PNEUMONIA INFECTION CAUSING LUNG ABSCESS: CASE REPORT
Authors
Muhammad Reza Al Hakim, Bramantono A
Source journal
Bulletin of Stomatology and Maxillofacial Surgery
Published
2025-11-28
Licence
Creative Commons Attribution-NonCommercial 4.0 International
Original
https://doi.org/10.58240/1829006X-2025.21.10-555

Abstract

Background:Lung abscess is a severe pulmonary infection characterized by localized suppuration and necrosis of lung parenchyma, often associated with high morbidity and mortality. Klebsiella pneumoniae is a frequent causative pathogen, especially in immunocompromised patients. Objectives:To present a case of lung abscess caused by Extended-Spectrum Beta-Lactamase (ESBL) producing Klebsiella pneumoniae in a patient with dual immunosuppression due to HIV infection and uncontrolled diabetes mellitus, and to highlight the clinical challenges in its management. Results:A 58-year-old male with HIV infection on regular antiretroviral therapy and uncontrolled type 2 diabetes mellitus presented with shortness of breath, productive cough, and fever. Radiological examination revealed a large cavitary lesion with an air-fluid level in the left hemithorax, accompanied by empyema and pneumothorax. Chest tube drainage yielded 1500 mL of purulent fluid. Microbiological culture identified ESBL Klebsiella pneumoniae. The patient was initially treated with intravenous levofloxacin and metronidazole, later switched to moxifloxacin based on antibiotic sensitivity, leading to significant clinical improvement. Conclusion:This case emphasizes the complexity of managing lung abscess in immunocompromised patients with uncontrolled comorbidities. Risk factors such as large cavity formation, empyema, multidrug-resistant pathogens, and poor metabolic control contribute to poor prognosis. Effective management requires adequate drainage, cultureguided antibiotic therapy, and control of underlying conditions. Prolonged antibiotic therapy with close radiological and clinical follow-up is recommended to optimize outcomes and prevent recurrence.
1 / ? 100% Open in new tab Download Cite

Loading the full text…

Download Follow Updates